{"id":12618,"date":"2026-07-28T04:05:32","date_gmt":"2026-07-27T20:05:32","guid":{"rendered":"http:\/\/longzhuplatform.com\/?p=12618"},"modified":"2026-07-28T04:05:32","modified_gmt":"2026-07-27T20:05:32","slug":"emcure-pharma-fineotex-chemical-%e0%a4%b8%e0%a4%b9%e0%a4%bf%e0%a4%a4-%e0%a4%87%e0%a4%a8-7-%e0%a4%b6%e0%a5%87%e0%a4%af%e0%a4%b0%e0%a5%8b%e0%a4%82-%e0%a4%aa%e0%a4%b0-%e0%a4%ac%e0%a5%8d%e0%a4%b0","status":"publish","type":"post","link":"http:\/\/longzhuplatform.com\/?p=12618","title":{"rendered":"Emcure Pharma, Fineotex Chemical \u0938\u0939\u093f\u0924 \u0907\u0928 7 \u0936\u0947\u092f\u0930\u094b\u0902 \u092a\u0930 \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u092c\u0941\u0932\u093f\u0936! 84% \u0915\u0940 \u0924\u0947\u091c\u0940 \u0915\u0940 \u0909\u092e\u094d\u092e\u0940\u0926- \u091a\u0947\u0915 \u0915\u0930\u0947\u0902 \u091f\u093e\u0930\u0917\u0947\u091f"},"content":{"rendered":"<p><\/p> <div> <p><strong>Stocks to BUY: <\/strong>\u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u092b\u0930\u094d\u092e\u094b\u0902 \u0928\u0947 \u091a\u0941\u0928\u093f\u0902\u0926\u093e \u0936\u0947\u092f\u0930\u094b\u0902 \u092a\u0930 \u0928\u0908 \u0915\u0935\u0930\u0947\u091c \u0936\u0941\u0930\u0942 \u0915\u0940 \u0939\u0948\u0964 \u0907\u0928\u092e\u0947\u0902 Tanfac Industries, Anthem Biosciences, Epigral, Emcure Pharmaceuticals, Privi Speciality Chemicals, Fineotex Chemical \u0914\u0930 HFCL \u0936\u093e\u092e\u093f\u0932 \u0939\u0948\u0902\u0964<\/p> <p>Choice Institutional Equities, DR Choksey Finserv, Systematix Institutional Equities, Motilal Oswal Financial Services \u0914\u0930 ICICIDirect Research \u0928\u0947 \u0907\u0928 \u0936\u0947\u092f\u0930\u094b\u0902 \u092a\u0930 \u092a\u0949\u091c\u093f\u091f\u093f\u0935 \u0930\u0947\u091f\u093f\u0902\u0917 \u0926\u0940 \u0939\u0948\u0964<\/p> <p><strong>1) Tanfac Industries: 38% \u0924\u0947\u091c\u0940 \u0915\u0940 \u0909\u092e\u094d\u092e\u0940\u0926<\/strong><\/p> <p>Choice Institutional Equities \u0928\u0947 Tanfac Industries \u092a\u0930 Buy \u0930\u0947\u091f\u093f\u0902\u0917 \u0915\u0947 \u0938\u093e\u0925 3,750 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u091f\u093e\u0930\u0917\u0947\u091f \u0926\u093f\u092f\u093e \u0939\u0948, \u091c\u094b \u0915\u0930\u0940\u092c 38% \u0905\u092a\u0938\u093e\u0907\u0921 \u0926\u093f\u0916\u093e\u0924\u093e \u0939\u0948\u0964 \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u0915\u0947 \u092e\u0941\u0924\u093e\u092c\u093f\u0915, Hydrofluoric Acid \u0915\u093e\u0930\u094b\u092c\u093e\u0930 \u092e\u0947\u0902 30 \u0938\u093e\u0932 \u0938\u0947 \u091c\u094d\u092f\u093e\u0926\u093e \u0915\u093e \u0905\u0928\u0941\u092d\u0935 \u0915\u0902\u092a\u0928\u0940 \u0915\u094b \u092c\u0922\u093c\u0924 \u0926\u0947\u0924\u093e \u0939\u0948\u0964 FY28 \u0924\u0915 \u092e\u093e\u0930\u094d\u091c\u093f\u0928 \u092c\u0922\u093c\u0915\u0930 23% \u092a\u0939\u0941\u0902\u091a\u0928\u0947 \u0915\u093e \u0905\u0928\u0941\u092e\u093e\u0928 \u0939\u0948\u0964<\/p> <p><strong>2) Anthem Biosciences: 818 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u091f\u093e\u0930\u0917\u0947\u091f<\/strong><\/p> <p>DR Choksey Finserv \u0928\u0947 Anthem Biosciences \u092a\u0930 Accumulate \u0930\u0947\u091f\u093f\u0902\u0917 \u0914\u0930 818 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u091f\u093e\u0930\u0917\u0947\u091f \u0926\u093f\u092f\u093e \u0939\u0948\u0964 \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u0915\u094b CRDMO \u0921\u093f\u092e\u093e\u0902\u0921 \u092e\u0947\u0902 \u0938\u0941\u0927\u093e\u0930 \u0914\u0930 \u092e\u091c\u092c\u0942\u0924 \u0915\u092e\u0930\u094d\u0936\u093f\u092f\u0932 \u092a\u093e\u0907\u092a\u0932\u093e\u0907\u0928 \u0938\u0947 \u0917\u094d\u0930\u094b\u0925 \u0915\u0940 \u0909\u092e\u094d\u092e\u0940\u0926 \u0939\u0948\u0964 FY26-FY28 \u0915\u0947 \u0926\u094c\u0930\u093e\u0928 PAT \u092e\u0947\u0902 21.6% CAGR \u0915\u093e \u0905\u0928\u0941\u092e\u093e\u0928 \u0939\u0948\u0964<\/p> <p><strong>3) Epigral: \u0938\u094d\u092a\u0947\u0936\u093f\u092f\u0932\u093f\u091f\u0940 \u0915\u0947\u092e\u093f\u0915\u0932\u094d\u0938 \u092a\u0930 \u0926\u093e\u0902\u0935<\/strong><\/p> <p>Systematix Institutional Equities \u0928\u0947 Epigral \u0915\u094b Buy \u0930\u0947\u091f\u093f\u0902\u0917 \u0926\u0940 \u0939\u0948\u0964 \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u0928\u0947 \u0915\u0930\u0940\u092c 19% \u0905\u092a\u0938\u093e\u0907\u0921 \u0915\u0947 \u0938\u093e\u0925 1,380 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u091f\u093e\u0930\u0917\u0947\u091f \u092c\u0924\u093e\u092f\u093e \u0939\u0948\u0964 \u0915\u0902\u092a\u0928\u0940 \u0915\u093e \u092b\u094b\u0915\u0938 \u0935\u0948\u0932\u094d\u092f\u0942-\u090f\u0921\u0947\u0921 \u0921\u0947\u0930\u093f\u0935\u0947\u091f\u093f\u0935\u094d\u0938 \u0914\u0930 \u0938\u094d\u092a\u0947\u0936\u093f\u092f\u0932\u093f\u091f\u0940 \u0915\u0947\u092e\u093f\u0915\u0932\u094d\u0938 \u092a\u0930 \u092c\u0922\u093c \u0930\u0939\u093e \u0939\u0948\u0964 \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u0915\u094b FY26-FY28 \u0915\u0947 \u0926\u094c\u0930\u093e\u0928 EBITDA \u092e\u0947\u0902 17% CAGR \u0915\u0940 \u0909\u092e\u094d\u092e\u0940\u0926 \u0939\u0948\u0964<\/p> <p><strong>4) Emcure Pharmaceuticals: 20% \u0905\u092a\u0938\u093e\u0907\u0921 \u0915\u093e \u0905\u0928\u0941\u092e\u093e\u0928<\/strong><\/p> <p>Motilal Oswal Financial Services \u0928\u0947 Emcure Pharmaceuticals \u092a\u0930 Buy \u0930\u0947\u091f\u093f\u0902\u0917 \u0914\u0930 2,260 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u091f\u093e\u0930\u0917\u0947\u091f \u0926\u093f\u092f\u093e \u0939\u0948\u0964 \u092f\u0939 \u0915\u0930\u0940\u092c 20% \u0905\u092a\u0938\u093e\u0907\u0921 \u0926\u093f\u0916\u093e\u0924\u093e \u0939\u0948\u0964 \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u0928\u0947 FY26-FY28 \u0915\u0947 \u0926\u094c\u0930\u093e\u0928 14% \u0930\u0947\u0935\u0947\u0928\u094d\u092f\u0942 CAGR \u0914\u0930 22% PAT CAGR \u0915\u093e \u0905\u0928\u0941\u092e\u093e\u0928 \u0932\u0917\u093e\u092f\u093e \u0939\u0948\u0964<\/p> <p><strong>5) Privi Speciality Chemicals: \u091f\u093e\u0930\u0917\u0947\u091f 4,490 \u0930\u0941\u092a\u092f\u0947<\/strong><\/p> <p>ICICIDirect Research \u0928\u0947 Privi Speciality Chemicals \u092a\u0930 Buy \u0930\u0947\u091f\u093f\u0902\u0917 \u0915\u0947 \u0938\u093e\u0925 4,490 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u091f\u093e\u0930\u0917\u0947\u091f \u0926\u093f\u092f\u093e \u0939\u0948\u0964 \u0907\u0938\u092e\u0947\u0902 \u0915\u0930\u0940\u092c 26% \u0905\u092a\u0938\u093e\u0907\u0921 \u0915\u0940 \u0938\u0902\u092d\u093e\u0935\u0928\u093e \u0939\u0948\u0964 \u0915\u0902\u092a\u0928\u0940 \u0905\u0917\u0932\u0947 2-3 \u0938\u093e\u0932 \u092e\u0947\u0902 \u0905\u092a\u0928\u0940 \u092e\u0948\u0928\u094d\u092f\u0941\u092b\u0948\u0915\u094d\u091a\u0930\u093f\u0902\u0917 \u0915\u094d\u0937\u092e\u0924\u093e 48,000 MTPA \u0938\u0947 \u092c\u0922\u093c\u093e\u0915\u0930 74,000 MTPA \u0915\u0930\u0928\u0947 \u0915\u0940 \u092f\u094b\u091c\u0928\u093e \u092a\u0930 \u0915\u093e\u092e \u0915\u0930 \u0930\u0939\u0940 \u0939\u0948\u0964<\/p> <p><strong>6) Fineotex Chemical: 29% \u0924\u0947\u091c\u0940 \u0915\u0940 \u0917\u0941\u0902\u091c\u093e\u0907\u0936<\/strong><\/p> <p>Choice Institutional Equities \u0928\u0947 Fineotex Chemical \u092a\u0930 Buy \u0930\u0947\u091f\u093f\u0902\u0917 \u0914\u0930 51 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u091f\u093e\u0930\u0917\u0947\u091f \u0926\u093f\u092f\u093e \u0939\u0948, \u091c\u094b \u0915\u0930\u0940\u092c 29% \u0905\u092a\u0938\u093e\u0907\u0921 \u0926\u093f\u0916\u093e\u0924\u093e \u0939\u0948\u0964 \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u0915\u0947 \u092e\u0941\u0924\u093e\u092c\u093f\u0915, CrudeChem Technologies \u092e\u0947\u0902 53% \u0939\u093f\u0938\u094d\u0938\u0947\u0926\u093e\u0930\u0940 \u0915\u0947 \u0905\u0927\u093f\u0917\u094d\u0930\u0939\u0923 \u0938\u0947 \u0915\u0902\u092a\u0928\u0940 \u0915\u0940 North American oilfield chemicals market \u092e\u0947\u0902 \u092e\u094c\u091c\u0942\u0926\u0917\u0940 \u092c\u0922\u093c\u0940 \u0939\u0948\u0964<\/p> <p><strong>7) HFCL: \u0938\u092c\u0938\u0947 \u091c\u094d\u092f\u093e\u0926\u093e 84% \u0905\u092a\u0938\u093e\u0907\u0921<\/strong><\/p> <p>DR Choksey Finserv \u0928\u0947 HFCL \u092a\u0930 Buy \u0930\u0947\u091f\u093f\u0902\u0917 \u0915\u0947 \u0938\u093e\u0925 362 \u0930\u0941\u092a\u092f\u0947 \u0915\u093e \u091f\u093e\u0930\u0917\u0947\u091f \u0926\u093f\u092f\u093e \u0939\u0948\u0964 \u092f\u0939 \u0915\u0930\u0940\u092c 84% \u0905\u092a\u0938\u093e\u0907\u0921 \u0926\u093f\u0916\u093e\u0924\u093e \u0939\u0948\u0964 \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u0915\u0947 \u092e\u0941\u0924\u093e\u092c\u093f\u0915, HFCL \u0918\u0930\u0947\u0932\u0942 EPC \u0906\u0927\u093e\u0930\u093f\u0924 \u091f\u0947\u0932\u0940\u0915\u0949\u092e \u0915\u0949\u0928\u094d\u091f\u094d\u0930\u0948\u0915\u094d\u091f\u0930 \u0938\u0947 \u090f\u0915\u094d\u0938\u092a\u094b\u0930\u094d\u091f \u0906\u0927\u093e\u0930\u093f\u0924 \u092a\u094d\u0930\u094b\u0921\u0915\u094d\u091f \u0914\u0930 \u091f\u0947\u0915\u094d\u0928\u094b\u0932\u0949\u091c\u0940 \u092a\u094d\u0932\u0947\u091f\u092b\u0949\u0930\u094d\u092e \u0915\u0940 \u0913\u0930 \u092c\u0922\u093c \u0930\u0939\u0940 \u0939\u0948\u0964 FY26-FY28 \u0915\u0947 \u0926\u094c\u0930\u093e\u0928 PAT \u092e\u0947\u0902 108% CAGR \u0915\u093e \u0905\u0928\u0941\u092e\u093e\u0928 \u0939\u0948\u0964<br \/>\u00a0<\/p> <\/div> <p>Stocks to BUY, Stocks to Buy Today, Brokerage Stock Recommendations, Tanfac Industries Share, Anthem Biosciences Share, Epigral Share, Emcure Pharmaceuticals Share, Privi Speciality Chemicals Share, Fineotex Chemical Share, HFCL Share, Buy Rating Stocks, Stock Market India, Brokerage Target Price, Multibagger Stocks, Best Stocks to Buy, Share Market News, Stocks with Upside Potential, Brokerage Picks 2026, Stock Recommendations 2026#Emcure #Pharma #Fineotex #Chemical #\u0938\u0939\u0924 #\u0907\u0928 #\u0936\u092f\u0930 #\u092a\u0930 #\u092c\u0930\u0915\u0930\u091c #\u092c\u0932\u0936 #\u0915 #\u0924\u091c #\u0915 #\u0909\u092e\u092e\u0926 #\u091a\u0915 #\u0915\u0930 #\u091f\u0930\u0917\u091f1785182732<\/p> ","protected":false},"excerpt":{"rendered":"<p>Stocks to BUY: \u092c\u094d\u0930\u094b\u0915\u0930\u0947\u091c \u092b\u0930\u094d\u092e\u094b\u0902 \u0928\u0947 \u091a\u0941\u0928\u093f\u0902\u0926\u093e \u0936\u0947\u092f\u0930\u094b\u0902 \u092a\u0930 \u0928\u0908 \u0915\u0935\u0930\u0947\u091c \u0936\u0941\u0930\u0942 \u0915\u0940 \u0939\u0948\u0964 \u0907\u0928\u092e\u0947\u0902 Tanfac Industries, Anthem Biosciences, Epigral, Emcure Pharmaceuticals, Privi Speciality Chemicals, Fineotex Chemical \u0914\u0930 HFCL \u0936\u093e\u092e\u093f\u0932 \u0939\u0948\u0902\u0964 Choice Institutional Equities, DR Choksey Finserv, Systematix Institutional Equities, Motilal Oswal Financial Services \u0914\u0930 ICICIDirect Research \u0928\u0947 \u0907\u0928 \u0936\u0947\u092f\u0930\u094b\u0902 \u092a\u0930 \u092a\u0949\u091c\u093f\u091f\u093f\u0935 \u0930\u0947\u091f\u093f\u0902\u0917 \u0926\u0940 \u0939\u0948\u0964 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":12619,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[37],"tags":[49139,40219,49147,49137,49146,49145,20205,14748,49141,49140,49149,49143,49144,4834,6685,49142,113,37880,49148,563,39287,46532,49138,7280,733,138,866,1063,1369,688,285,1364,3242,290,1066],"class_list":["post-12618","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-content-marketing","tag-anthem-biosciences-share","tag-best-stocks-to-buy","tag-brokerage-picks-2026","tag-brokerage-stock-recommendations","tag-brokerage-target-price","tag-buy-rating-stocks","tag-chemical","tag-emcure","tag-emcure-pharmaceuticals-share","tag-epigral-share","tag-fineotex","tag-fineotex-chemical-share","tag-hfcl-share","tag-multibagger-stocks","tag-pharma","tag-privi-speciality-chemicals-share","tag-share-market-news","tag-stock-market-india","tag-stock-recommendations-2026","tag-stocks-to-buy","tag-stocks-to-buy-today","tag-stocks-with-upside-potential","tag-tanfac-industries-share","tag-7280","tag-733","tag-138","tag-866","tag-1063","tag-1369","tag-688","tag-285","tag-1364","tag-3242","tag-290","tag-1066"],"acf":[],"_links":{"self":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts\/12618","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=12618"}],"version-history":[{"count":0,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/posts\/12618\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=\/wp\/v2\/media\/12619"}],"wp:attachment":[{"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=12618"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=12618"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/longzhuplatform.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=12618"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}